1123 Cytokinetics Amgen
BioCentury & Getty Images

Deals

Cytokinetics evaluating path forward for heart disease treatment after Amgen ends partnership

Nov 23, 2020 | 7:30 PM GMT

Cytokinetics is assessing whether to commercialize omecamtiv mecarbil on its own or to seek a new partner after Amgen returned the

Read the full 459 word article

How to gain access

Continue reading with a
two-week free trial.